10岁以下儿童二尖瓣修复:困难还是成功?
先天性二尖瓣疾病手术死亡率为5%、晚期死亡率为10%,6年再手术累积发生率为38.6%±8.3%。结论认为二尖瓣修复是有效的治疗选择,但常仅延迟瓣膜置换时间。
要点
- 10岁以下儿童二尖瓣修复可用于先天性及获得性二尖瓣疾病。
- 先天性二尖瓣疾病术后6年再手术累积发生率为38.6%±8.3%。
- 修复常仅推迟瓣膜置换,需长期随访再手术风险。
核心结论
- 在10岁以下儿童中,二尖瓣修复是二尖瓣疾病的有效治疗选择,但常仅延迟瓣膜置换时间。
主要发现
- 先天性二尖瓣疾病患儿修复时中位年龄1.2岁(范围14天至9.8年),获得性二尖瓣疾病患儿为1.9岁(范围10天至9.9年)。
- 先天性二尖瓣疾病患者中,二尖瓣修复指征为二尖瓣反流者31例(77.5%);获得性二尖瓣疾病患者全部因二尖瓣反流手术。
- 先天性二尖瓣疾病患者手术死亡率为5%,晚期死亡率为10%;获得性二尖瓣疾病患者无死亡。
- 先天性二尖瓣疾病患者6年再手术累积发生率为38.6%±8.3%。
临床怎么用
- 对于10岁以下二尖瓣疾病患儿,二尖瓣修复可作为有效治疗选择,但应告知家属再手术及后续瓣膜置换的可能性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Mitral valve (MV) repair in children is challenging because of the broad spectrum of lesions and anticipated patient growth. The purpose of the study was to evaluate the outcome of MV repair in children below 10 years of age. METHODS: We reviewed all MV repair procedures performed in children below 10 years of age. Endpoints of the study were survival after MV repair and cumulative incidence of reoperation. RESULTS: MV repair was performed in 40 patients with congenital MV disease (MVD) and in 10 patients with acquired MVD. Median age at time of repair for congenital MVD was 1.2 years (range, 14 days to 9.8 years) and for acquired MVD 1.9 years (range, 10 days to 9.9 years). Indication for MV repair was mitral regurgitation in 31 congenital MVD patients (77.5%) and in all acquired MVD patients. In patients with congenital MVD operative mortality was 5% and late mortality was 10%. No deaths occurred in patients with acquired MVD. Patients with congenital mitral regurgitation showed a better, yet not significant, 6-year survival than patients with congenital mitral stenosis (85.3% ± 8.2% vs 60% ± 18.2%, P = .1). In patients with congenital MVD cumulative incidence of reoperation at 6 years was 38.6% ± 8.3%. CONCLUSIONS: In children below 10 years of age, MV repair is an effective treatment option for MVD. However it often just delays the time to valve replacement.
引用
- Mayr B, Vitanova K, Burri M, et al. Mitral Valve Repair in Children Below Age 10 Years: Trouble or Success? Ann Thorac Surg. 2020. PMID: 32240647. doi:10.1016/j.athoracsur.2020.02.057
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。